A HUGE THANK YOU to Alan and Pauline Coe with Trotty, one of the horses involved in the attempt.

Livvy's family, friends and everybody at The Hare and Hounds  are overwhelmed by the generosity of everybody who has donated prizes and money for Livvy's cause.

Your kindness and help has generated £40,000.00 so far for Olivia's cause!

Teenage Cancer is something that we should all be aware of, and Livvy is a remarkably brave young lady.

So if you haven't donated please dig deep, and be generous.

You can still show your support by donating to Livvy's Just Giving page:

Olivia was diagnosed with chondroblastic osteosarcoma, a severe form of bone cancer, in the left pelvis in February just days after her fifteenth birthday.

After 30 weeks of chemotherapy at UCLH the tumour had not shrunk so the only option was to undergo major surgery.

"Go hard or go home" is the expression Livvy used whilst on a carriage ride with Alan Coe, after he suggested they wait until the rain had passed. They took the carriage drive together just before Livvy bravely underwent surgery to remove the tumour in her hip.

On 3rd November Olivia had an 8 and a half hour operation in which her left leg, pelvis and sacrum were amputated.

Alan Coe drove several pairs of horses from The Hare and Hounds, Layer Breton, Colchester. The journey was over 100 miles non-stop to Fakenham Racecourse in Norfolk.

Alan Coe, who specialises in horse hoof care and runs his own commercial carriage driving business, is dedicated in raiseing thousands of pounds to improve 16-year-old Olivia Coughlan’s life.

The Hare and Hounds also dedicated to Livvy's cuase, held a  fundraising weekend over the May Bank Holiday.

"She is an incredibly brave, vibrant, charming young lady." Said Mr and Mrs King. "We ask that you all support Livvy and this cause"

The Bob Champion Cancer Trust team based within the Trust's laboratories is focused in understanding the detailed molecular basis of the development of prostate cancer. Success of this reserach will ultimately lead to better clinical management of this cancer and to new cancer tests and treatments.